Skip to main content

NovoLog Mix 70/30

NDC 70518-2119 · REMEDYREPACK INC.

Generic nameinsulin aspart
Dosage formINJECTION, SUSPENSION
RouteSUBCUTANEOUS
Active ingredient(s)INSULIN ASPART
Strength100 [iU]/mL
Pharmacologic classInsulin Analog [EPC], Insulin [CS]
Marketing categoryBLA

Packages

70518-2119-0 — 5 SYRINGE, PLASTIC in 1 CARTON (70518-2119-0) / 3 mL in 1 SYRINGE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0169-6338 — insulin aspart, 0169-6339 — insulin aspart, 0169-7501 — insulin aspart, 50090-1664 — insulin aspart, 50090-1678 — insulin aspart, 50090-2272 — insulin aspart, 50090-4500 — insulin aspart, 50090-4955 — insulin aspart, 50090-4956 — insulin aspart, 50090-4959 — insulin aspart, 70518-3236 — insulin aspart, 70518-3865 — insulin aspart, 71288-903 — insulin aspart-fsan, 71288-904 — insulin aspart-fsan, 73070-100 — insulin aspart, 73070-102 — insulin aspart, 73070-103 — insulin aspart, 73070-200 — insulin aspart, 73070-203 — insulin aspart, 83257-007 — insulin aspart-xjhz, +14 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels